Skip to main content
Erschienen in: Clinical and Experimental Nephrology 5/2013

01.10.2013 | Review Article

Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides

verfasst von: J. Charles Jennette

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

The nomenclature and classification of vasculitis has been difficult and controversial for many decades. This is problematic both for research on vasculitis as well as clinical care of patients with vasculitis. The first (1994) International Chapel Hill Consensus Conference on the Nomenclature of Systemic Vasculitides (CHCC) proposed names and definitions for the most common forms of vasculitis. Since then, there have been substantial advances in our understanding of vasculitis and changes in medical terminology. In addition, CHCC 1994 did not propose a nomenclature for some relatively common forms of vasculitis, such as vasculitis secondary to other diseases. To address these issues, a second International Chapel Hill Consensus Conference was held in 2012. The goals were to change names and definitions as appropriate, and add important categories of vasculitis not included in CHCC 1994. This overview summarizes the 2012 CHCC and points out the changes compared to the 1994 CHCC. Notable changes include the introduction of new terms such as granulomatosis with polyangiitis, eosinophilic granulomatosis with polyangiitis and immunoglobulin A vasculitis and the inclusion of categories for variable vessel vasculitis and secondary forms of vasculitis.
Literatur
1.
Zurück zum Zitat Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CGM, McCluskey RT, Sinico RA, Rees AJ, van Es LA, Waldherr R, Wiik A. Nomenclature of systemic vasculitides: the proposal of an international consensus conference. Arthritis Rheum. 1994;37:187–92.PubMedCrossRef Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CGM, McCluskey RT, Sinico RA, Rees AJ, van Es LA, Waldherr R, Wiik A. Nomenclature of systemic vasculitides: the proposal of an international consensus conference. Arthritis Rheum. 1994;37:187–92.PubMedCrossRef
2.
Zurück zum Zitat Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CGM, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DGI, Specks U, Stone JH, Takahashi K, Watts RA. 2012 Revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65:1–11.PubMedCrossRef Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CGM, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DGI, Specks U, Stone JH, Takahashi K, Watts RA. 2012 Revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65:1–11.PubMedCrossRef
3.
Zurück zum Zitat Guillevin L, Lhote F, Amouroux J, Gherardi R, Callard P, Casassus P. Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg–Strauss syndrome: indications for the classification of vasculitides of the polyarteritis Nodosa Group. Br J Rheumatol. 1996;35:958–64.PubMedCrossRef Guillevin L, Lhote F, Amouroux J, Gherardi R, Callard P, Casassus P. Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg–Strauss syndrome: indications for the classification of vasculitides of the polyarteritis Nodosa Group. Br J Rheumatol. 1996;35:958–64.PubMedCrossRef
4.
Zurück zum Zitat Jennette JC, Falk RJ, Hu P, Xiao H. Pathogenesis of anti-neutrophil cytoplasmic autoantibody associated small vessel vasculitis. Annu Rev Pathol Mech Dis. 2013;8:139–60.CrossRef Jennette JC, Falk RJ, Hu P, Xiao H. Pathogenesis of anti-neutrophil cytoplasmic autoantibody associated small vessel vasculitis. Annu Rev Pathol Mech Dis. 2013;8:139–60.CrossRef
5.
Zurück zum Zitat Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, Baslund B, Brenchley P, Bruchfeld A, Chaudhry AN, Cohen Tervaert JW, Deloukas P, Feighery C, Gross WL, Guillevin L, Gunnarsson I, Harper L, Hrušková Z, Little MA, Martorana D, Neumann T, Ohlsson S, Padmanabhan S, Pusey CD, Salama AD, Sanders JS, Savage CO, Segelmark M, Stegeman CA, Tesař V, Vaglio A, Wieczorek S, Wilde B, Zwerina J, Rees AJ, Clayton DG, Smith KG. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med. 2012;367:214–23.PubMedCrossRef Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, Baslund B, Brenchley P, Bruchfeld A, Chaudhry AN, Cohen Tervaert JW, Deloukas P, Feighery C, Gross WL, Guillevin L, Gunnarsson I, Harper L, Hrušková Z, Little MA, Martorana D, Neumann T, Ohlsson S, Padmanabhan S, Pusey CD, Salama AD, Sanders JS, Savage CO, Segelmark M, Stegeman CA, Tesař V, Vaglio A, Wieczorek S, Wilde B, Zwerina J, Rees AJ, Clayton DG, Smith KG. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med. 2012;367:214–23.PubMedCrossRef
6.
Zurück zum Zitat Lionaki S, Blyth ER, Hogan SL, Hu Y, Senior JBA, Jennette CE, Nachman PH, Jennette JC, Falk RJ. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum. 2012;64:3452–62.PubMedCrossRef Lionaki S, Blyth ER, Hogan SL, Hu Y, Senior JBA, Jennette CE, Nachman PH, Jennette JC, Falk RJ. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum. 2012;64:3452–62.PubMedCrossRef
7.
Zurück zum Zitat Falk RJ, Gross WL, Guillevin L, Hoffman G, Jayne DRW, Jennette JC, et al. “Granulomatosis with polyangiitis (Wegener’s)”: an alternative name for “Wegener’s granulomatosis”. A joint proposal of the American College of Rheumatology, the American Society of Nephrology, and the European League Against Rheumatism. Ann Rheum Dis. 2011;70:704.PubMedCrossRef Falk RJ, Gross WL, Guillevin L, Hoffman G, Jayne DRW, Jennette JC, et al. “Granulomatosis with polyangiitis (Wegener’s)”: an alternative name for “Wegener’s granulomatosis”. A joint proposal of the American College of Rheumatology, the American Society of Nephrology, and the European League Against Rheumatism. Ann Rheum Dis. 2011;70:704.PubMedCrossRef
8.
Zurück zum Zitat Falk RJ, Gross WL, Guillevin L, Hoffman G, Jayne DRW, Jennette JC, et al. “Granulomatosis with polyangiitis (Wegener’s)”: an alternative name for “Wegener’s granulomatosis”. A joint proposal of the American College of Rheumatology, the American Society of Nephrology, and the European League Against Rheumatism. J Am Soc Nephrol. 2011;22:587–8.PubMedCrossRef Falk RJ, Gross WL, Guillevin L, Hoffman G, Jayne DRW, Jennette JC, et al. “Granulomatosis with polyangiitis (Wegener’s)”: an alternative name for “Wegener’s granulomatosis”. A joint proposal of the American College of Rheumatology, the American Society of Nephrology, and the European League Against Rheumatism. J Am Soc Nephrol. 2011;22:587–8.PubMedCrossRef
9.
Zurück zum Zitat Falk RJ, Gross WL, Guillevin L, Hoffman G, Jayne DRW, Jennette JC, et al. “Granulomatosis with polyangiitis (Wegener’s)”: an alternative name for “Wegener’s granulomatosis”. A joint proposal of the American College of Rheumatology, the American Society of Nephrology, and the European League Against Rheumatism. Arthritis Rheum. 2011;63:863–4.PubMedCrossRef Falk RJ, Gross WL, Guillevin L, Hoffman G, Jayne DRW, Jennette JC, et al. “Granulomatosis with polyangiitis (Wegener’s)”: an alternative name for “Wegener’s granulomatosis”. A joint proposal of the American College of Rheumatology, the American Society of Nephrology, and the European League Against Rheumatism. Arthritis Rheum. 2011;63:863–4.PubMedCrossRef
10.
Zurück zum Zitat Sinico RA, Di Toma L, Maggiore U, Tosoni C, Bottero P, Sabadini E, et al. Renal involvement in Churg-Strauss syndrome. Am J Kidney Dis. 2006;47:770–9.PubMedCrossRef Sinico RA, Di Toma L, Maggiore U, Tosoni C, Bottero P, Sabadini E, et al. Renal involvement in Churg-Strauss syndrome. Am J Kidney Dis. 2006;47:770–9.PubMedCrossRef
11.
Zurück zum Zitat Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, Renfrow MB, et al. The pathophysiology of IgA nephropathy. J Am Soc Nephrol. 2011;22:1795–803.PubMedCrossRef Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, Renfrow MB, et al. The pathophysiology of IgA nephropathy. J Am Soc Nephrol. 2011;22:1795–803.PubMedCrossRef
Metadaten
Titel
Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides
verfasst von
J. Charles Jennette
Publikationsdatum
01.10.2013
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 5/2013
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-013-0869-6

Weitere Artikel der Ausgabe 5/2013

Clinical and Experimental Nephrology 5/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.